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Abstract In the present work, synchrotron radiation
Fourier-transform infrared (SRFTIR) and Raman micro-
spectroscopies were used to evaluate a possible role of
creatine in the pathogenesis and progress of pilocarpine-
evoked seizures and seizure-induced neurodegenerative
changes in the rat hippocampal tissue. The main goal of
this study was to identify creatine deposits within the
examined brain area, to analyze their frequency in epileptic
animals and naive controls and to examine correlations
between the number of inclusions in the hippocampal
formation of epileptic rats and the quantitative parameters
describing animal behavior during 6-h observation period
after pilocarpine injection. The presence of creatine in the
brain tissue was confirmed based on the vibrational bands
specific for this compound in the infrared and Raman
spectra. These were the bands occurring at the wave-
numbers around 2800, 1621, 1398, and 1304 cm
−1 in IR
spectra and around 1056, 908 and 834 cm
−1 in the Raman
spectra. Creatine was detected in eight of ten analyzed
epileptic samples and in only one of six controls under the
study. The number of deposits in epileptic animals varied
from 1 to 100 and a relative majority of inclusions were
detected in the area of the Dentate Gyrus and in the
multiform hippocampal layer. Moreover, the number of
creatine inclusions was positively correlated with the total
time of seizure activity.
Keywords Pilocarpine-induced epilepsy.Creatine
deposits.SRFTIR microspectroscopy and imaging.Raman
microspectroscopy
Introduction
Epilepsy is one of the most frequently occurring neurolog-
ical diseases. It is characterized by recurrent spontaneous
seizures leading, without an appropriate therapeutic treat-
ment, to severe cognitive and social impairments [1–4].
Changes underlying these impairments include seizure-
induced variations in tissue levels of glutamate or GABA
(gamma-aminobutyric acid), excessive activation of gluta-
mate receptors, oxidative stress, overexpression of cyto-
kines and finally apoptosis or necrosis of nerve cells [5, 6].
Despite the intensive investigations, the mechanisms
underlying the mentioned abnormalities still remain poorly
understood.
Animal models of epilepsy are valuable tools to study
the pathogenesis of this disease and to evaluate potential
antiepileptic drugs [7, 8]. Chronic models of acquired
(symptomatic) epilepsy include those in which epilepsy-
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DOI 10.1007/s00216-011-5488-zlike conditions are evoked by electrical (kindling model) or
pharmacological stimuli (for example, pilocarpine and
kainate models) in previously healthy animals, mostly rats
[7]. In the most frequently used model of temporal lobe
epilepsy, following the pilocarpine-induced seizures, nu-
merous brain structures which are involved in the epilep-
tiform activity may display different degrees of
neurodegeneration, depending on the seizure intensity and
duration. The neurodegenerative changes are particularly
located in the sectors 1 and 3 of the Ammon’s horn (CA1
and CA3, respectively) [9] and among the processes
suspected of leading to hippocampal anomalies, oxidative
stress accompanying mitochondrial dysfunction is mainly
taken into account [10].
In our previous studies, we analyzed the biochemical
changes occurring in the CA3 sector and dentate gyrus
(DG) of the rat hippocampal formation in the acute period
after pilocarpine injection [11]. In animals suffering from
seizures, we observed changes in the secondary structure of
proteins (from α-helical to β-sheet) and the saturation level
of phospholipids. The mentioned abnormalities were
detected in the pyramidal cell layer of CA3 and in the
multiform and molecular layers of DG area.
Carrying out the measurements using SRFTIR micro-
spectroscopy, crystalline inclusions of unknown origin were
noticed within hippocampal formation from epileptic
animals. The preliminary analysis done during this exper-
iment suggested that the mentioned deposits included
creatine. Because similar creatine inclusions have been
previously observed in the hippocampus of amyloid
precursor protein transgenic mice as well as in the autopsy
samples from people deceased with Alzheimer’s disease or
amyotrophic lateral sclerosis [12–15], we decided to
continue our study and verify the possible role of creatine
in the pathogenesis and progress of pilocarpine-evoked
seizures and seizure-induced neurodegenerative changes.
Brain, constituting only 2% of body mass, consumes
almost 20% of total body energy requirements [16]. The
most energy used in the nervous system is provided in the
form of ATP by mitochondria [17]. Creatine, being a
nitrogenous organic amino acid, plays important roles in
this process. Creatine is an element of the brain creatine/
phosphocreatine/creatine kinase (Cr/PCr/CK) system which
serves as a temporal and spatial energy buffer [18].
However, the energy storage and a high-energy phosphate
shuttle from mitochondria to the cytoplasmic places of
consumption are not the only functions of creatine. It can
also play a role in protein synthesis and in its phosphory-
lated form in membrane stabilization [19, 20]. Additionally,
the studies of Almeida et al. showed that creatine had also
to be considered as a neuromodulator or co-transmitter
which was able to modify the activity of some postsynaptic
receptors [21].
The key significance of creatine for the energetic metab-
olism and its other functions in the CNS have been evidenced
by creatine deficiency syndromes resulting from inborn errors
ofcreatinesynthesis ortransport.Patientssufferingfromthem
present clinical features including severe mental retardation,
movement disorders, autism, and epilepsy [22, 23].
Troubles in CNS energy metabolism of different origin
play critical roles in the progression of neurological diseases
as a primary or secondary mechanism in neuronal death
cascade. Therefore, the therapeutic potential of creatine for
brain pathologies has recently been tested using animal
models of neurodegenerative disorders, such as Parkinson’s
disease, Huntington’s disease or amyotrophic lateral sclerosis
[24–28]. In Parkinson’s disease, the treatment with creatine
resulted in a significant protection against both CNS
dopamine depletion and neuronal loss in the substantia nigra
[24]. In an animal model of Huntington’sd i s e a s e ,c r e a t i n e
supplementation increased animals’ life span, decreased their
brain atrophy and delayed the formation of mutant huntingtin
aggregates [25]. For these two diseases also ongoing clinical
trials seem to be very promising in contrast to amyotrophic
lateral sclerosis for which subsequent clinical tests did not
confirm efficacy of the treatment with the creatine [29–31].
In the present paper, two measurement techniques, i.e.,
SRFTIRandRamanmicrospectroscopywereusedtoexamine
the possible role of creatine in the process of epileptogenesis.
Analysis of vibrational modes of molecules allowed us to
detect creatine deposits within rat nervous tissue and to
compare the frequencies of their occurrence in the postepi-
leptic and control hippocampal formations. Additionally,
correlations between the numbers of creatine inclusions and
the animal seizure behavior parameters within the 6-h period
after pilocarpine injection were calculated.
Materials and methods
Animals
All animal-use procedures were approved by the Bioethical
Commission of the Jagiellonian University in accordance
with international standards. Adult male Wistar rats were
obtained from an animal colony of the Institute of
Pediatrics, Collegium Medicum, Jagiellonian University,
Krakow and maintained under conditions of controlled
temperature (20±2 °C) and illumination (12-h light:12-
h dark cycle). A solid diet (Labofeed) and water were
available ad libitum.
Epilepsy induction and behavioral observations
The cholinergic agonist, pilocarpine, was used in order to
induce seizures in rats. Pilocarpine was injected intra-
2268 J. Dulinska et al.peritoneally (300 mg/kg, Sigma P6503) on the postnatal
day 60. Scopolamine methyl bromide (1 mg/kg, Sigma
S8502) was injected i.p. 30 min prior to pilocarpine to
reduce its peripheral effects. After pilocarpine injection, the
rats were continuously observed during the 6-h period.
Motor symptoms were rated on the six-point scale used in
our previous studies [32]. Additionally, the observations
provided the data on general parameters of the status
epilepticus such as: (1) the latency of the first motor sign,
(2) the time when it occurred within the 6-h observation
period, and (3) the time when the acute period ended. Ten
epileptic animals were used in this study, four with
intermediate and six with heavy seizures. The latency of
the first motor signs varied from 10 to 20 min, while the
duration of seizure activity within the observation period
varied from 180 to 350 min.
Sample preparation
After 6-h observation of the animals’ behavior, the rats
were perfused with physiological saline solution of high
analytical purity. The skulls were opened, and the brains
were excised and deeply frozen in liquid nitrogen.
Afterwards, they were cut with a cryomicrotome into 10-
μm thick sections. The sections containing the dorsal part
of the hippocampal formation were placed on MirrIR low-e
microscopic slides and stored at −70 ° C. The presence of
creatine deposits was examined in the hippocampal tissue
of ten epileptic and six control animals.
Data acquisition
The measurements of tissue samples were carried out in
February 2010 at the SMIS beamline of SOLEIL synchro-
tron (Saint Aubin, France). SRFTIR microspectroscopy was
the main analytical technique used in the investigation. The
measurements were carried out in transflection mode using
a Continuum XL infrared microscope equipped with a
50 μm MCT detector and coupled to an FTIR ThermoNi-
colet 5700 spectrometer. The beam size was reduced to 10×
10 μm
2 using a double pass aperture to eliminate diffraction
and a 32× NA 0.6 infinity corrected Schwarzschild
objective. Infrared spectra were recorded between 650 and
4000 cm
−1 by co-adding 64 scans for each individual
sample spectrum at a nominal physical resolution of
6c m
−1. Spectra were collected and analyzed using the data
acquisition software OMNIC (Version 8.0).
Raman microspectroscopy was used as an additional
complementary measurement technique. The main goal of
its application was to confirm the results obtained using
SRFTIR microspectroscopy and to verify whether the
observed creatine deposits were localized within the
analyzed tissue and were not laboratory contaminants.
All Raman measurements were recorded using a DXR
Raman microscope (ThermoNicolet) equipped with a
780 nm ThermoNicolet laser providing 14 mW of power
on sample, edge filters, a charge coupled device detector
and a 100×/0.9 numerical aperture objective giving a spot
size of 0.9 μm at 780 nm. The spectra were recorded with
one accumulation of 80 s from 50 to 3400 cm
−1. The
microspectrometer was operated in non-confocal mode with
a pinhole of 50 μm and a 400 lines/mm grating, giving a
spectral resolution varying from 10.1 to 18.5 cm
−1. For
depth profiles, vertical steps of 2 μm were performed
through around 10 μm thick sample, and 2.5 μm steps were
used for horizontal maps in the plan of the section.
The only pre-treatment performed on IR and Raman spectra
was baseline correction. The mentioned procedure was used
only in case of comparisons of the spectra from hippocampal
inclusions, normal tissue and creatine (see Figs. 1 and 4).
Chemical mapping of selected IR or Raman bands was done
based on their areas after baseline subtraction. In this case, no
preprocessing was performed on the spectral data.
Results
SRFTIR microspectroscopy study
The detailed microscopic observations of tissue slices
including the hippocampal formation of epileptic animals
showed the presence of quite a large number of inclusions of
unknown origin.The preliminary measurementsdonein2008
at SMIS beamline of SOLEIL suggested the presence of
creatine in the mentioned deposits. Therefore, we decided to
use two complementary measurement techniques, namely
SRFTIR and Raman microspectroscopies in order to examine
the possible role of creatine in the pathogenesis and progress
ofpilocarpine-induced epilepticseizures. Forthispurpose,the
point IR maps were recorded for all the inclusions found
within the area of the hippocampal formation in ten epileptic
and six control samples.
Fig. 1 The comparison of baseline corrected IR absorption spectra
recorded for the analyzed hippocampal inclusion (B), pure creatine
(C) and normal hippocampal tissue (A)
An increased frequency of creatine inclusions following seizures 2269In Fig. 1, a typical spectrum of the analyzed hippocam-
pal inclusion was compared with that from normal nervous
tissue and with the spectrum of pure creatine.
The presence of creatine in the examined inclusions was
confirmed based on the IR absorption bands characteristic
for this compound and occurring at the wavenumbers
around 2800, 1621, 1398, and 1304 cm
−1 [15]. Addition-
ally, in order to exclude the presence of phosphocreatine
within the deposits, for some of them two dimensional IR
imaging was done and the obtained distributions of
intensities of creatine bands were compared with chemical
maps obtained for the absorption bands specific for the
compounds containing phosphate group(s). In Fig. 2, the
results of such chemical mapping carried out for inclusions
from the selected CA3 epileptic area were presented.
Similar maps recorded for epileptic DG area were presented
in Electronic Supplementary Material Figure S1.
As one can notice from Fig. 2, a higher absorption of IR
radiation at 1398 and 1304 cm
−1 and lower at 1225 and
1080 cm
−1 was correlated with the positions of inclusions
what suggested that they contained creatine but not
phosphocreatine.
From among six control samples only one contained
creatine inclusions (25 inclusions mostly at multiform
layer). In case of epileptic group, creatine aggregates were
observed in eight of ten animals under investigation and the
number of inclusions varied from 1 to 100.
In order to verify if the localization of creatine deposits is
characteristic for specific cellular layers or regions of
hippocampal formation the mean and median values of their
number in the compared areas were calculated for epileptic
group (eight epileptic animals in which creatine deposits were
observed).Thenumberofcreatineinclusionsinthe pyramidal
(pyr), granular (gran), multiform (mult), and molecular (mol)
layers as well as in the areas of DG, hilus of DG, CA3, and
CA1–CA2 were presented in Table 1 and Fig. 3.
As one can notice from Table 1 and Fig. 3, a relative
majority of creatine inclusions was localized in the
multiform layer and in the area of DG.
The further step of the investigation was to analyze
correlations between the number of inclusions in the analyzed
areas and the quantitative parameters describing the seizure
behaviors induced by pilocarpine injection. The following
behavioral parameters were taken into account: the latency of
the first motor signs (T1), the maximal intensity of seizures
(MAX) and the duration of the acute period (T). Spearman’s
rank correlation coefficients (rs) were used as a measure of
strength of the dependence between the number of creatine
inclusions and the behavioral parameters. The values of
Spearman’s rank correlation coefficients calculated for the
examined cellular layers and areas of the hippocampal
formation were presented in Table 2.
Taking into account the number of the analyzed samples
the Spearman’s rank correlation coefficient was treated as
Fig. 2 Chemical maps obtained
for CA3 hippocampal area pre-
senting the distributions of cre-
atine absorption bands (∼1398
and ∼1304 cm
−1) in comparison
with the distributions of bands
specific for the absorption of
lipids (∼2921 cm
−1) and com-
pounds containing phosphate
groups (∼1225 and
∼1080 cm
−1). The images were
generated from the baseline-
subtracted areas of the analyzed
absorption bands. The hippo-
campal inclusions were marked
with arrows
Table 1 The median and aver-
age values of the number of
creatine inclusions in specific
cellular layers and hippocampal
regions in epileptic samples
Cellular layer Region Total
pyr gran mult mol DG H CA3 CA1–CA2
Median 2 1 8 7 4 2 0 4 21
Average 7 7 14 9 12 6 6 12 35
SD 3 3 6 3 5 3 3 5 15
2270 J. Dulinska et al.significant when its absolute value was ≥0.7 and the values
fulfilling this condition were marked. The following
correlations were observed between the number of creatine
deposits and the parameters describing rat behavior in the
acute period of status epilepticus:
– The quantity of creatine inclusions in granular (rs=
0.76, p<0.05) and molecular (rs=0.80, p<0.05) layers
was positively correlated with the total time of epileptic
activity;
– Similar relation was observed for the DG (rs=0.85,
p<0.05) and for the whole hippocampal formation
(rs=0.74, p<0.05);
– The negative, statistically significant correlation, but
with the absolute value of Spearman’s rank correlation
coefficient less than 0.7, (rs=−0.61, p<0.05) was found
between the number of deposits in DG and the latency
of the first motor signs.
In the next step of the analysis, the epileptic animals
were divided into two groups: rats with intermediate
(MAX=1.5 or 2) and heavy seizures (MAX=2.5 or 3).
The first group included four whilst the second six
animals. For both groups the medians of the number of
creatine inclusions in specific cellular layers/areas were
evaluated and the differences between them were tested
using the U Mann–Whitney test. The mentioned statistical
test did not confirm the existence of a significant
difference in the number of deposits between the animals
with intermediate and heavy seizures.
Raman microspectroscopy study
The results obtained using Raman spectroscopy evidently
confirmed that the inclusions observed previously using
SRFTIR microspectroscopy consisted of creatine. In Fig. 4,
the Raman spectra recorded for normal nervous tissue,
hippocampal inclusion and pure creatine were compared.
The sharp shape of the bands present in the spectrum (B)
may suggest the crystalline nature of the deposit.
In order to verify if creatine inclusions were present
within the nervous tissue and were not laboratory contam-
inants on tissue surface, the line or 2D Raman depth
profiles were recorded. As an example, one of them was
presented in Fig. 5. Based on such measurements, we were
able to confirm that creatine was located within the nervous
tissue and the vertical size of the deposits varied between a
few to around 20 μm.
Discussion and conclusions
The main goal of this study was to identify creatine
deposits and to analyze their frequency in the hippocampal
tissue in rats with pilocarpine-induced seizures and in naive
controls. To achieve these goals, two complementary
measurement techniques, allowing for analysis of vibra-
tional modes of molecules, SRFTIR and Raman micro-
spectroscopy, were used. The presence of creatine in the
investigated inclusions was confirmed based on the
Fig. 3 The number of creatine inclusions in specific cellular layers (A)a n da r e a s( B) of the hippocampal formation in eight epileptic samples with
creatine deposits. The data for samples 1–4 were magnified in insets
Table 2 The values of
Spearman’s rank correlation
coefficients for the examined
cellular layers and regions of
the hippocampal formation
Cellular layer Region Total
pyr gran mult mol DG H CA3 CA1–CA2
T1 −0.20 −0.51 −0.04 −0.35 −0.61 −0.42 −0.04 0.04 −0.38
MAX −0.18 0.38 −0.08 −0.09 0.26 0.07 −0.40 −0.05 −0.02
T 0.44 0.76 0.30 0.80 0.85 0.53 0.27 0.32 0.74
An increased frequency of creatine inclusions following seizures 2271occurrence of the bands specific for the analyzed compound
in the vibrational spectra. For IR absorption spectra, these
were the bands occurring at the wavenumbers around 2800,
1621, 1398, and 1304 cm
−1. In turn, in Raman spectra the
bands around 1056, 908, and 834 cm
−1 were mainly taken
into account [12].
Our results showed that the frequency of creatine
deposits was significantly higher in the animals with
pilocarpine-induced seizures than in the control group.
Creatine inclusions were detected in only one of six control
animals while the presence of creatine was confirmed for
80% of epileptic animals. Thus, we can expect that the
presence of creatine deposits may be an effect of patholog-
ical conditions occurring in the brain during the acute phase
of status epilepticus.
During epileptic seizures there is an increased energy
demand, and Cr/PCr/CK system may play a pivotal role in
providing the energy necessary for seizure progression [33].
The presence of creatine deposits in epileptic animals may
suggest a disturbed function of mitochondrial creatine
kinase (CK) catalyzing creatine phosphorylation. Such a
conclusion is very probable, taking into account the fact
that reactive oxygen species can inactivate mitochondrial
CK, by changing its octameric conformation into an
inactivated dimeric form [21] and the data concerning an
excessive free radical formation and lipid peroxidation
Fig. 4 The comparison of baseline corrected Raman spectra recorded
for the analyzed hippocampal inclusion (B), pure creatine (C) and
normal hippocampal tissue (A)
Fig. 5 Raman microspectroscopy data showing hippocampal inclu-
sions within the brain tissue. The spectral data were recorded in the
vertical plane from +5 to −6 μm in depth from the surface of the tissue
section along a 50 μm line. A Bright field image of two hippocampal
inclusions; the red line overlays the axis of the depth slice. B Spectral
image generated from the area of the C–H band containing signal from
tissue and creatine. The surface of the tissue section appears clearly
delineated at this wavelength (3–3.3 μm). C Spectral image generated
from the area of the 850–815 cm
−1 band from creatine showing that
the two inclusions are integrated within the nervous tissue. D Spectral
image generated from the area of the amide I band from proteins. The
surface of the section appears more fuzzy in this wavelength range (6–
7 μm). E Spectra extracted from the map: normal tissue (blue),
hippocampal inclusion (red) and glass beneath the tissue (green). The
bands used to generate the spectral images are marked by stars
2272 J. Dulinska et al.observed in different brain areas during status epilepticus
induced by pilocarpine and in the lithium–pilocarpine
model [34–38]. In agreement with such thesis are also our
previous results showing an increased lipid saturation (a
marker of excessive oxidative stress) and conformational
changes of proteins in the DG and CA3 hippocampal areas
from animals treated with pilocarpine [11].
On the other hand, the study of Almeida et al. [21]
showed that creatine was released from central neurons in a
manner typical of classical neurotransmitters—upon depo-
larization of brain tissue depending on the level of
extracellular Ca
2+ ions and involving activation of
voltage-dependent Na
+ and K
+ channels. The level of
electrically evoked creatine release was diminished in the
absence of extracellular Ca
2+. On the other hand, the
blockade of action-potential with an Na
+ channel inhibitor
reduced, whereas the blockade of K
+ channels enhanced its
electrically stimulated release [21]. Taking into account the
results of Almeida et al. and the conditions occurring in the
nerve cells during excessive discharges, we conclude that
the increased frequency of creatine inclusions may also be
connected with its neuromodulatory role.
For many years, cerebral creatine was believed to be
principally of peripheral origin [39], but the works of
Braissant et al. showed that glycineamidinotransferase and
guanidinoacetate methyltransferase, two enzymes necessary
for creatine synthesis and function, were also expressed in
the brain and, therefore, the brain was shown to be capable
of its own creatine synthesis [40, 41]. However, in spite of
brain synthesis of creatine, according to Tachikawa et al.
[42], the brain barriers might be key determinants of the
levels of guanidine compounds, including creatine, in the
brain and cerebrospinal fluid. Since, changes in the blood–
brain barrier permeability may be a common outcome of
single and repeated seizures, the other possible explanation
for the increased presence of creatine deposits in the
epileptic brain may be seizure-induced blood–brain barrier
damage resulting in its increased permeability for peripheral
creatine [43].
Conclusions
In the present work, SRFTIR and Raman microspectros-
copies were used to confirm the presence of creatine in
inclusions localized within the hippocampal tissue from rats
with pilocarpine-induced seizures. The comparison of
epileptic and control rats showed for the first time an
increased frequency of creatine inclusions in the epileptic
animals. Additionally, the number of inclusions detected in
the epileptic animals was positively correlated with the total
time of seizure activity within the 6-h observation period.
The obtained results may suggest seizure-induced disrup-
tion of creatine kinase function, impairment of neuro-
modulatory function of creatine or increased permeability
of the blood–brain barrier for creatine from periphery.
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